"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 6 | 7 | 13 |
1995 | 11 | 5 | 16 |
1996 | 10 | 4 | 14 |
1997 | 9 | 0 | 9 |
1998 | 13 | 1 | 14 |
1999 | 8 | 4 | 12 |
2000 | 12 | 2 | 14 |
2001 | 12 | 5 | 17 |
2002 | 22 | 9 | 31 |
2003 | 32 | 13 | 45 |
2004 | 30 | 7 | 37 |
2005 | 35 | 11 | 46 |
2006 | 31 | 12 | 43 |
2007 | 41 | 10 | 51 |
2008 | 43 | 9 | 52 |
2009 | 36 | 4 | 40 |
2010 | 45 | 4 | 49 |
2011 | 54 | 11 | 65 |
2012 | 51 | 4 | 55 |
2013 | 59 | 5 | 64 |
2014 | 52 | 6 | 58 |
2015 | 74 | 9 | 83 |
2016 | 71 | 11 | 82 |
2017 | 65 | 3 | 68 |
2018 | 74 | 6 | 80 |
2019 | 76 | 7 | 83 |
2020 | 75 | 6 | 81 |
2021 | 85 | 3 | 88 |
2022 | 67 | 0 | 67 |
2023 | 67 | 0 | 67 |
2024 | 24 | 4 | 28 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Electron transport chain inhibition increases cellular dependence on purine transport and salvage. Cell Metab. 2024 Jul 02; 36(7):1504-1520.e9.
-
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer. JAMA Oncol. 2024 Jun 01; 10(6):799-806.
-
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC. J Thorac Oncol. 2024 Jun; 19(6):877-882.
-
Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2024 Jul; 193:107832.
-
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study. Mol Cancer. 2024 May 30; 23(1):115.
-
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction. Respirology. 2024 Jul; 29(7):563-573.
-
Neoadjuvant or Perioperative Approach in Lung Cancer. N Engl J Med. 2024 May 16; 390(19):1816-1818.
-
The risk analysis index is an independent predictor of outcomes after lung cancer resection. PLoS One. 2024; 19(5):e0303281.
-
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer. Int J Mol Sci. 2024 May 08; 25(10).
-
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial. Oncologist. 2024 May 03; 29(5):e690-e698.